Novo Nordisk CEO testifies at Senate over weight loss drug prices
Novo Nordisk‘s top executive faces a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and diabetes
[...]
Eli Lilly and Co
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with
[...]
Medicare releases prices for first 10 drugs subject to negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C.,
[...]
Eli Lilly (LLY) earnings Q2 2024
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as
[...]
Novo Nordisk, Eli Lilly shares slide on Roche’s obesity drug trial
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel. SEBASTIEN BOZON | AFP | Getty Images Novo Nordisk and Eli
[...]
